https://www.arabsciencepedia.org/w/index.php?action=history&feed=atom&title=%D9%81%D9%8A%D8%B2%D8%AA%D9%8A%D8%A8%D9%8A%D9%86%D8%AA فيزتيبينت - تاريخ المراجعة 2026-05-14T07:12:39Z تاريخ التعديل لهذه الصفحة في الويكي MediaWiki 1.43.6 https://www.arabsciencepedia.org/w/index.php?title=%D9%81%D9%8A%D8%B2%D8%AA%D9%8A%D8%A8%D9%8A%D9%86%D8%AA&diff=37515&oldid=prev سلام المجذوب: أنشأ الصفحة ب'{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 399133414 | IUPAC_name = (2''S'')-''N''-[(1''R'')-1-[3,5-bis(trifluoromethyl)phenyl]ethy...' 2016-02-27T12:21:22Z <p>أنشأ الصفحة ب&#039;{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 399133414 | IUPAC_name = (2&#039;&#039;S&#039;&#039;)-&#039;&#039;N&#039;&#039;-[(1&#039;&#039;R&#039;&#039;)-1-[3,5-bis(trifluoromethyl)phenyl]ethy...&#039;</p> <p><b>صفحة جديدة</b></p><div>{{Drugbox<br /> | Verifiedfields = changed<br /> | Watchedfields = changed<br /> | verifiedrevid = 399133414<br /> | IUPAC_name = (2&#039;&#039;S&#039;&#039;)-&#039;&#039;N&#039;&#039;-[(1&#039;&#039;R&#039;&#039;)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-&#039;&#039;N&#039;&#039;-methylpiperazine-1-carboxamide<br /> | image = Vestipitant structure.svg<br /> <br /> &lt;!--Clinical data--&gt;<br /> | tradename =<br /> | pregnancy_AU = &lt;!-- A / B1 / B2 / B3 / C / D / X --&gt;<br /> | pregnancy_US =<br /> | pregnancy_category =<br /> | legal_AU = &lt;!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --&gt;<br /> | legal_CA = &lt;!-- / Schedule I, II, III, IV, V, VI, VII, VIII --&gt;<br /> | legal_UK = &lt;!-- GSL / P / POM / CD / Class A, B, C --&gt;<br /> | legal_US =<br /> <br /> &lt;!--Pharmacokinetic data--&gt;<br /> | bioavailability =<br /> | protein_bound =<br /> | metabolism =<br /> | excretion =<br /> <br /> &lt;!--Identifiers--&gt;<br /> | IUPHAR_ligand = 5757<br /> | CAS_number_Ref = {{cascite|correct|??}}<br /> | CAS_number = 334476-64-1<br /> | CAS_supplemental =<br /> | ATC_prefix = none<br /> | ATC_suffix =<br /> | PubChem = 9832383<br /> | DrugBank_Ref = {{drugbankcite|correct|drugbank}}<br /> | DrugBank =<br /> | UNII_Ref = {{fdacite|changed|FDA}}<br /> | UNII = S052TOI9BI<br /> | ChEMBL_Ref = {{ebicite|changed|EBI}}<br /> | ChEMBL = 522987<br /> | ChemSpiderID = 8008111<br /> <br /> &lt;!--Chemical data--&gt;<br /> | C=23 | H=21 | F=10 | N=3 | O=1 <br /> | molecular_weight = 545.416 g/mol<br /> | smiles = FC(F)(F)c1cc(F)ccc1C2CNCCN2C(=O)N(C)C(C)c3cc(C(F)(F)F)cc(c3)C(F)(F)F<br /> | StdInChI = 1S/C23H24F7N3O/c1-13-8-18(24)4-5-19(13)20-12-31-6-7-33(20)21(34)32(3)14(2)15-9-16(22(25,26)27)11-17(10-15)23(28,29)30/h4-5,8-11,14,20,31H,6-7,12H2,1-3H3/t14-,20-/m1/s1<br /> | StdInChIKey = SBBYBXSFWOLDDG-JLTOFOAXSA-N<br /> }}<br /> <br /> &#039;&#039;&#039;فيزتيبينت Vestipitant&#039;&#039;&#039; هو دواء طور من قبل شركة جلاكسو سميث كلاين، يعمل بمثابة مناهض انتقائي لمستقبلات NK1. قيد التطوير كدواء مضاد للقىء ومزيل للقلق المحتمل، وكعلاج لل[[طنين]] والأرق.<br /> <br /> {{Antiemetics and antinauseants}}<br /> {{Antidepressants}}<br /> {{Anxiolytics}}<br /> {{Neuropeptide agonists and antagonists}}<br /> <br /> [[Category:NK1 receptor antagonists]]<br /> [[Category:Organofluorides]]<br /> [[Category:Piperazines]]<br /> [[Category:Amides]]<br /> <br /> {{gastrointestinal-drug-stub}}<br /> {{nervous-system-drug-stub}}</div> سلام المجذوب